Velleca Mark A.
Director at G1 Therapeutics, Inc.
- Sold, on record
- $8.9M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Aug 8, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- G1 Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.UnusualAug 16, 2022 2022
Sold 80,000 shares at $12.64 ($1M)
Velleca Mark A., Director
Sold 40.8% of holdings ($2.5M position)116,000 shares left2.7x usual sizeFiling
- 2 Form 4 sale G1 Therapeutics, Inc.Plan not statedSep 20, 2022 +35 days
Sold 20,000 shares at $13.50 ($270k)
Velleca Mark A., Director
Sold 14.7% of holdings ($1.8M position)116,000 shares left0.7x usual sizeFiling
- 3 Form 4 sale G1 Therapeutics, Inc.Plan not statedOct 18, 2022 +28 days
Sold 15,000 shares at $11.70 ($176k)
Velleca Mark A., Director
Sold 11.5% of holdings ($1.5M position)116,000 shares left0.5x usual sizeFiling
- 4 Form 144 notice G1 Therapeutics, Inc.NoticeAug 8, 2023 +294 days
Filed to sell 60,000 shares ($120k)
Velleca Mark A., Director
10b5-1 plan3x usual sizeFiling
- 5 Form 4 sale G1 Therapeutics, Inc.UnusualAug 8, 2023 same day
Sold 60,000 shares at $2.00 ($120k)
Velleca Mark A., Director
10b5-1 planSold 34.1% of holdings ($352k position)116,000 shares left3x usual sizeFollows a Form 144Filing
- 6 Form 144 notice G1 Therapeutics, Inc.NoticeDec 12, 2023 +126 days
Filed to sell 60,000 shares ($204k)
Velleca Mark A., Director
10b5-1 plan1.5x usual sizeFiling
- 7 Form 144 notice G1 Therapeutics, Inc.NoticeJan 9, 2024 +28 days
Filed to sell 60,000 shares ($192k)
Velleca Mark A., Director
10b5-1 plan1.5x usual sizeFiling
- 8 Form 144 notice G1 Therapeutics, Inc.NoticeApr 9, 2024 +91 days
Filed to sell 28,393 shares ($136k)
Velleca Mark A., Director
10b5-1 plan0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Apr 9, 2024 | G1 Therapeutics, Inc. | Director | Form 144 notice | 28,393 | $136k | Notice | SEC | |
| Jan 9, 2024 | Jan 9, 2024 | G1 Therapeutics, Inc. | Director | Form 144 notice | 60,000 | $192k | Notice | SEC | |
| Dec 12, 2023 | Dec 12, 2023 | G1 Therapeutics, Inc. | Director | Form 144 notice | 60,000 | $204k | Notice | SEC | |
| Aug 8, 2023 | Aug 10, 2023 | G1 Therapeutics, Inc. | Director | Form 4 sale | 60,000 | $120k | 34.1% | Unusual | SEC |
| Aug 8, 2023 | Aug 8, 2023 | G1 Therapeutics, Inc. | Director | Form 144 notice | 60,000 | $120k | Notice | SEC | |
| Oct 18, 2022 | Oct 20, 2022 | G1 Therapeutics, Inc. | Director | Form 4 sale | 15,000 | $176k | 11.5% | Plan not stated | SEC |
| Sep 20, 2022 | Sep 22, 2022 | G1 Therapeutics, Inc. | Director | Form 4 sale | 20,000 | $270k | 14.7% | Plan not stated | SEC |
| Aug 16, 2022 | Aug 18, 2022 | G1 Therapeutics, Inc. | Director | Form 4 sale | 80,000 | $1M | 40.8% | Unusual | SEC |
| Jul 15, 2021 | Jul 15, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $570k | 33.0% | Unusual | SEC |
| Jun 17, 2021 | Jun 17, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $659k | 33.0% | Unusual | SEC |
| May 13, 2021 | May 13, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $597k | 42.3% | Unusual | SEC |
| Apr 15, 2021 | Apr 15, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $734k | 42.3% | Unusual | SEC |
| Feb 18, 2021 | Feb 18, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 31,040 | $925k | 43.1% | Unusual | SEC |
| Jan 21, 2021 | Jan 21, 2021 | G1 Therapeutics, Inc. | Director | Form 4 sale | 30,000 | $630k | 42.3% | Unusual | SEC |
| Dec 17, 2020 | Dec 17, 2020 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 30,000 | $586k | 44.8% | Unusual | SEC |
| Nov 15, 2018 | Nov 16, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 5,000 | $199k | 20.8% | Plan not stated | SEC |
| Oct 15, 2018 | Oct 15, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 5,000 | $208k | 20.8% | Plan not stated | SEC |
| Sep 17, 2018 | Sep 19, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 5,000 | $332k | 35.7% | Unusual | SEC |
| Aug 15, 2018 | Aug 17, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 5,000 | $279k | 35.7% | Unusual | SEC |
| Jul 16, 2018 | Jul 17, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 5,000 | $210k | 35.7% | Unusual | SEC |
| May 15, 2018 | May 16, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $347k | 100.0% | Unusual | SEC |
| Apr 16, 2018 | Apr 17, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $270k | 100.0% | Unusual | SEC |
| Mar 15, 2018 | Mar 16, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $287k | 100.0% | Unusual | SEC |
| Feb 15, 2018 | Feb 16, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $150k | 100.0% | Unusual | SEC |
| Jan 16, 2018 | Jan 17, 2018 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $172k | 100.0% | Unusual | SEC |
| Dec 18, 2017 | Dec 20, 2017 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,500 | $150k | 100.0% | Unusual | SEC |